In contrast to the present clinical strategy, which focuses mostly on treating symptoms, regenerative medicine aims to restore tissue or organs that have been damaged by disease, trauma, or congenital abnormalities. Tissue engineering, cellular therapy, medicinal gadgets, and artificial organs are among the technologies employed to achieve these goals. Combinations of these treatments can speed up our natural healing process in areas where it's most required, or take over the function of an organ that's been irreversibly damaged. Regenerative medicine is a relatively young subject that brings together professionals from biology, chemistry, computer science, engineering, genetics, medicine, robotics, and other domains to solve some of humanity's most difficult medical challenges. The goal of regenerative medicine is to create and implement innovative treatments to mend tissues and organs and restore function that has been lost due to aging, disease, injury, or abnormalities. In many aspects, the human body has the natural ability to heal itself. Cell therapy and tissue engineering are two therapeutic methods used in regenerative medicine. Cell and tissue cultures are used in cell therapy approaches to replace morphological structures, tissues, and functions. Tissue engineering is a process that combines biological and technical techniques to construct structures and devices such as scaffolds, matrices, and 3D biocompatible materials to complement cell treatment.
Important Alert:
X
Title : 30,000 nano implants in humans with no infections, no loosening, and no failures
Thomas J Webster, Interstellar Therapeutics, United States
Title : Cell and gene therapies in models of vascular brain disorders
Berislav V Zlokovic, University of Southern California, United States
Title : Artificial Intelligence (AI) in biomedical engineering
Hossein Hosseinkhani, Innovation Center for Advanced Technology, Matrix HT, United States
Title : 3D Bio printed cardiovascular tissue model for space based applications
Kunal Mitra, Florida Tech, United States
Title : Challenges in skeletal tissue engineering
Patrizia Ferretti, UCL Great Ormond Street Institute of Child Health, United Kingdom
Title : Human-like cancer tissue models as a drug screening platform
Karolina Valente, VoxCell BioInnovation, Canada